Charity

Euroscicon managing director sets up a new charitable venture

Off

Dr Shara Cohen and Professor Tim CoxAt the end of July Euroscicon’s managing director  Dr Shara Cohen,  met with Professor Timothy Cox to discuss the way forward for Euroscicons new charitable arm RareCareUK.

Professor Cox has a long standing interest in forwarding research in the rare diseases.

His laboratory is currently developing gene therapy for serious neurodegenerative disorders, including Tay-Sachs and Sandhoff diseases and plays a major role in researching the causes of and developing treatments for  Krabbes disease and Gaucher disease.

In addition Professor Cox  and his group in Cambridge have  well established  links with charities and Government-sponsored bodies, which can help bring laboratory work  to the patients who need to benefit from the research.

Dr Cohen said “we hope that RareCareUK will have a long and rewarding relationship with Professor Cox and thank him for his time, ongoing support and most of all his enthusiasm for what we are hoping to achieve”.

RSS Free Biotechnology & Pharmaceuticals Magazines

  • Achieve Operational Excellence Throughout the Product Lifecycle
    CIOs recently have set goals to address process inefficiencies in the product lifecycle. Organizations are investing significant time and energy in process improvements to eliminate silos, increase operational excellence, and deliver patient value. Download this ebook to learn how life sciences companies can streamline processes throughout the product lifecycle to reduce cycle times, increase transparency […]